Thermo Fisher Scientific Inc (TMO)
580.05
-4.10
(-0.70%)
USD |
NYSE |
Mar 18, 16:00
581.00
+0.95
(+0.16%)
Pre-Market: 20:00
Thermo Fisher Scientific Shareholders Equity (Quarterly): 46.74B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 46.74B |
September 30, 2023 | 45.33B |
June 30, 2023 | 43.75B |
March 31, 2023 | 42.26B |
December 31, 2022 | 43.98B |
September 30, 2022 | 43.55B |
June 30, 2022 | 42.29B |
March 31, 2022 | 40.96B |
December 31, 2021 | 40.79B |
September 30, 2021 | 38.71B |
June 30, 2021 | 36.85B |
March 31, 2021 | 35.06B |
December 31, 2020 | 34.51B |
September 30, 2020 | 31.82B |
June 30, 2020 | 29.88B |
March 31, 2020 | 28.56B |
December 31, 2019 | 29.68B |
September 30, 2019 | 29.36B |
June 30, 2019 | 28.73B |
March 31, 2019 | 27.69B |
December 31, 2018 | 27.59B |
September 30, 2018 | 26.89B |
June 30, 2018 | 26.44B |
March 31, 2018 | 26.12B |
December 31, 2017 | 25.41B |
Date | Value |
---|---|
September 30, 2017 | 24.70B |
June 30, 2017 | 22.39B |
March 31, 2017 | 21.80B |
December 31, 2016 | 21.54B |
September 30, 2016 | 21.66B |
June 30, 2016 | 21.26B |
March 31, 2016 | 20.92B |
December 31, 2015 | 21.35B |
September 30, 2015 | 20.85B |
June 30, 2015 | 20.68B |
March 31, 2015 | 19.91B |
December 31, 2014 | 20.55B |
September 30, 2014 | 20.51B |
June 30, 2014 | 20.66B |
March 31, 2014 | 20.43B |
December 31, 2013 | 16.86B |
September 30, 2013 | 16.44B |
June 30, 2013 | 15.80B |
March 31, 2013 | 15.60B |
December 31, 2012 | 15.46B |
September 30, 2012 | 15.29B |
June 30, 2012 | 15.09B |
March 31, 2012 | 15.29B |
December 31, 2011 | 15.04B |
September 30, 2011 | 15.20B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
27.69B
Minimum
Mar 2019
46.74B
Maximum
Dec 2023
37.02B
Average
37.78B
Median
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 163.89M |
XWELL Inc | 19.40M |
ProPhase Labs Inc | 56.43M |
Applied DNA Sciences Inc | 4.232M |
OncoCyte Corp | 37.56M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 98.73B |
Total Liabilities (Quarterly) | 51.88B |
Debt to Equity Ratio | 0.7471 |
Current Ratio | 1.755 |
Net Debt Paydown Yield | -0.56% |